You are not expected to do this alone
A new genetic diagnosis brings a flood of unfamiliar words and decisions. This module is a practical orientation — how to read what you are handed, who to ask, and where the trustworthy information lives. None of it replaces your care team; it helps you talk with them.
How to read a genetic report
A genetic test report can look intimidating. A few things to look for:
- The gene and the variant. Somewhere it names the gene (e.g., *CASK*) and the specific change in HGVS shorthand (e.g., a
c.coding change and ap.protein change — see the Genetics 101 module). - The classification. The report should say whether the variant is pathogenic, likely pathogenic, a variant of uncertain significance (VUS), likely benign, or benign. A VUS genuinely means "we do not know yet," and classifications can be updated over time.
- Zygosity and inheritance. Whether one or both copies are affected, and whether the variant was inherited or de novo (new in the child).
- What was and was not tested. A negative result for one test does not rule out everything.
If anything is unclear — and it often is — that is exactly what a genetic counselor is for. Bring the report to the appointment.
Finding a clinical geneticist or genetic counselor
- A clinical geneticist is a physician who diagnoses and manages genetic conditions.
- A genetic counselor is a specialist who explains results, inheritance, and options in plain language, and supports families through decisions.
Many families reach these specialists through a referral from a pediatrician or neurologist, or through a genetics clinic at a children's or academic hospital. Patient-advocacy organizations (below) can also help point you toward clinicians experienced with rare conditions.
What registries and clinical trials are
- A patient registry collects information from many people with the same condition, with their consent. Registries help researchers learn the natural history of a rare condition — how it typically changes over time — which is foundational for ever testing a treatment. Joining one is often one of the most useful things a family can do for the wider community.
- A clinical trial is a carefully designed study that tests whether a treatment is safe and whether it works, in real people, in stages (phases). Trials have eligibility rules and are voluntary. Most rare-disease treatment ideas are *not yet* at the trial stage — and a treatment being "in a trial" does not yet mean it works. ClinicalTrials.gov is the public registry of trials in the U.S. and many other countries.
Always discuss any trial with your care team before acting on it, and be cautious of anything that asks for payment to participate or promises a cure.
Curated authoritative resources
The Key resources section below this module links to government and nonprofit sources you can trust for further reading — including rare-disease information centers (NIH GARD, NORD, Orphanet), genetics explainers (MedlinePlus Genetics), variant and gene databases (ClinVar, NCBI Gene, OMIM), expert disease summaries (GeneReviews), the trials registry (ClinicalTrials.gov), and U.S. health agencies (FDA, NINDS). These are starting points for learning — not a substitute for your clinical team.
> This is educational, not medical advice, and not an endorsement of any specific clinic, trial, or product. Decisions about care, testing, and trials belong with you and your clinical team.